Ontology highlight
ABSTRACT:
SUBMITTER: ElHalawani H
PROVIDER: S-EPMC4524527 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ElHalawani Hesham H Abdel-Rahman Omar O
Therapeutics and clinical risk management 20150728
Gastric (GC) and gastroesophageal junction (GEJ) cancers are two global health problems with a relatively high mortality, particularly in the advanced stage. Inhibition of angiogenesis is now contemplated as a classic treatment preference for myriad tumor types encompassing renal cell carcinoma, non-small cell lung cancer, colorectal cancer, glioblastoma, and ovarian cancer, among others. Bevacizumab and ramucirumab have been widely investigated in GC and GEJ cancer, with some controversy about ...[more]